Logo image of SLGC

SOMALOGIC INC (SLGC) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:SLGC - US83444K1051 - Common Stock

2.1 USD
-0.1 (-4.55%)
Last: 1/5/2024, 8:26:28 PM
2 USD
-0.1 (-4.76%)
After Hours: 1/5/2024, 8:26:28 PM

SLGC Key Statistics, Chart & Performance

Key Statistics
Market Cap396.23M
Revenue(TTM)81.73M
Net Income(TTM)-130.38M
Shares188.68M
Float175.53M
52 Week High3.79
52 Week Low1.73
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.69
PEN/A
Fwd PEN/A
Earnings (Next)03-26 2024-03-26/amc
IPO2021-02-23
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


SLGC short term performance overview.The bars show the price performance of SLGC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20

SLGC long term performance overview.The bars show the price performance of SLGC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of SLGC is 2.1 USD. In the past month the price decreased by -22.51%. In the past year, price decreased by -19.54%.

SOMALOGIC INC / SLGC Daily stock chart

SLGC Latest News, Press Relases and Analysis

SLGC Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.62 215.59B
DHR DANAHER CORP 29.89 162.76B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 181.32 55.10B
A AGILENT TECHNOLOGIES INC 25.71 40.67B
IQV IQVIA HOLDINGS INC 19.17 37.96B
MTD METTLER-TOLEDO INTERNATIONAL 33.6 28.72B
WAT WATERS CORP 31.17 23.56B
ILMN ILLUMINA INC 30.94 20.61B
WST WEST PHARMACEUTICAL SERVICES 37.76 19.21B
MEDP MEDPACE HOLDINGS INC 39.21 15.80B
TEM TEMPUS AI INC N/A 13.36B
RVTY REVVITY INC 21.61 11.74B

About SLGC

Company Profile

SLGC logo image SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company is headquartered in Boulder, Colorado and currently employs 451 full-time employees. The company went IPO on 2021-02-23. The firm has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. The company develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The company offers SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. Its products include SomaScan Assay, SomaScan Certified Sites, SomaSignal Tests and SOMAmer Reagents. SomaScan Assay is utilized for Research Use Only (RUO) applications. Its SomaScan Assay measures approximately 7,000 protein target measurements in a single sample. Its SOMAmer reagents are proprietary modified aptamers, which are short, synthetic single-stranded DNA (ssDNA) sequences developed to bind specific protein targets with high affinity and specificity across the proteome.

Company Info

SOMALOGIC INC

C/O Somalogic, Inc., 2945 Wilderness Place

Boulder COLORADO US

Employees: 451

SLGC Company Website

Phone: 13036259000

SOMALOGIC INC / SLGC FAQ

Can you describe the business of SOMALOGIC INC?

SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company is headquartered in Boulder, Colorado and currently employs 451 full-time employees. The company went IPO on 2021-02-23. The firm has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. The company develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The company offers SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. Its products include SomaScan Assay, SomaScan Certified Sites, SomaSignal Tests and SOMAmer Reagents. SomaScan Assay is utilized for Research Use Only (RUO) applications. Its SomaScan Assay measures approximately 7,000 protein target measurements in a single sample. Its SOMAmer reagents are proprietary modified aptamers, which are short, synthetic single-stranded DNA (ssDNA) sequences developed to bind specific protein targets with high affinity and specificity across the proteome.


What is the current price of SLGC stock?

The current stock price of SLGC is 2.1 USD. The price decreased by -4.55% in the last trading session.


Does SOMALOGIC INC pay dividends?

SLGC does not pay a dividend.


How is the ChartMill rating for SOMALOGIC INC?

SLGC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Where is SOMALOGIC INC (SLGC) stock traded?

SLGC stock is listed on the Nasdaq exchange.


Can you provide the PE ratio for SLGC stock?

SOMALOGIC INC (SLGC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.69).


What is SOMALOGIC INC worth?

SOMALOGIC INC (SLGC) has a market capitalization of 396.23M USD. This makes SLGC a Small Cap stock.


SLGC Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to SLGC. When comparing the yearly performance of all stocks, SLGC is a bad performer in the overall market: 78% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SLGC Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SLGC. SLGC has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SLGC Financial Highlights

Over the last trailing twelve months SLGC reported a non-GAAP Earnings per Share(EPS) of -0.69. The EPS decreased by -50% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -23.08%
ROE -26.25%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%33.33%
Sales Q2Q%-47.13%
EPS 1Y (TTM)-50%
Revenue 1Y (TTM)-19.73%

SLGC Forecast & Estimates

10 analysts have analysed SLGC and the average price target is 4.01 USD. This implies a price increase of 91.05% is expected in the next year compared to the current price of 2.1.

For the next year, analysts expect an EPS growth of -2.43% and a revenue growth -12.14% for SLGC


Analysts
Analysts80
Price Target4.01 (90.95%)
EPS Next Y-2.43%
Revenue Next Year-12.14%

SLGC Ownership

Ownership
Inst Owners0.05%
Ins Owners0.46%
Short Float %N/A
Short RatioN/A